Introduction: Who Should Undergo Diagnostics

If you experience symptoms such as difficulty swallowing, unexplained weight loss, pain behind your breastbone, or persistent hoarseness, it’s important to seek medical attention. These signs may indicate oesophageal cancer, although they can also be caused by other, less serious conditions. People with risk factors such as tobacco use, heavy alcohol consumption, or a history of Barrett’s oesophagus should be especially vigilant about these symptoms.^[5][13]

Early evaluation is advisable because oesophageal cancer often doesn’t cause noticeable symptoms until it has already grown considerably. The oesophagus is a flexible, muscular tube that naturally stretches to accommodate food, which means tumours can grow quite large before they start blocking the passage and causing swallowing difficulties. By the time many people notice symptoms, the cancer may have already reached an advanced stage.^[19]

Anyone who has been told they have abnormal cells in their oesophagus, especially high-grade dysplasia, should undergo regular diagnostic monitoring. High-grade dysplasia is considered a precancerous condition that can develop into cancer if left untreated. Regular check-ups and diagnostic tests allow doctors to catch any changes early, when treatment is most likely to be successful.^[5]

Classic Diagnostic Methods

The journey to diagnosing oesophageal squamous cell carcinoma typically begins with a physical examination and a review of your medical history. Your doctor will ask about your symptoms, how long you’ve had them, and any risk factors you may have, such as smoking or alcohol use. This initial assessment helps guide which tests should be performed next.^[5][13]

A chest X-ray is often one of the first imaging tests ordered. An X-ray uses energy beams that pass through your body to create pictures of your internal organs and bones. While a chest X-ray cannot definitively diagnose oesophageal cancer, it can reveal abnormalities that warrant further investigation, such as unusual masses or changes in the structure of the oesophagus or nearby tissues.^[5][13]

Esophagoscopy, also called upper endoscopy, is the primary procedure used to examine the inside of the oesophagus. During this test, a thin, flexible tube called an esophagoscope is gently inserted through your mouth or nose, down your throat, and into your oesophagus. The esophagoscope has a light and a small camera at its tip, allowing the doctor to see the lining of your oesophagus in detail and identify any abnormal areas.^[5][13]

If the doctor sees suspicious tissue during the esophagoscopy, they will perform a biopsy. A biopsy involves removing a small sample of tissue from the abnormal area. This sample is then examined under a microscope by a specialist called a pathologist, who looks for cancer cells. The biopsy is the only way to confirm whether cancer is present and to determine what type of cancer it is, such as squamous cell carcinoma.^[5][9]

Once cancer is confirmed, additional imaging tests are needed to determine the stage of the cancer, which describes how far it has grown and whether it has spread. Computed tomography, or CT scan, is a common imaging test that uses X-rays and a computer to create detailed, three-dimensional pictures of the inside of your body. A CT scan of your chest and abdomen can show whether the cancer has spread to nearby lymph nodes or other organs such as the liver or lungs.^[5][13]

Another important imaging test is magnetic resonance imaging, or MRI. An MRI uses strong magnets and radio waves instead of X-rays to create detailed images of your body’s soft tissues. MRI scans are particularly useful for seeing how deeply the cancer has grown into the wall of the oesophagus and whether it has invaded nearby structures such as the tissue covering the lungs, the outer covering of the heart, or the diaphragm.^[7]

Positron emission tomography, known as a PET scan, is often combined with a CT scan to create what’s called a PET-CT scan. In a PET scan, a small amount of radioactive sugar is injected into your bloodstream. Cancer cells, which tend to use more sugar than normal cells, absorb more of this radioactive substance and show up as bright spots on the scan. This test is especially helpful for detecting cancer that has spread to distant parts of the body, such as bones or distant lymph nodes.^[7]

For stage III oesophageal squamous cell carcinoma specifically, staging depends on several factors. Doctors need to know how deeply the tumour has grown into the layers of the oesophagus wall, which are made up of different tissues including the inner lining, muscle layers, and outer covering. They also need to know how many nearby lymph nodes contain cancer cells. In stage III disease, the cancer may have grown through the thick muscle wall or outer layer of the oesophagus, and it may have spread to up to six nearby lymph nodes. However, there is no sign that it has spread to distant body parts.^{[2][4][12][17]}

Stage III squamous cell cancer can be further divided into stage 3A and stage 3B, depending on the exact depth of tumour growth and the number of affected lymph nodes. Stage 3A typically means the cancer has grown no further than the thick muscle wall and has spread to up to six nearby lymph nodes. Stage 3B means the cancer has spread into the thick muscle wall or outer layer, or it has invaded nearby tissues such as the covering of the lungs, the outer covering of the heart, or the diaphragm. It might also have spread to up to six lymph nodes.^[4][12][17]

There are two main ways doctors stage oesophageal cancer: clinical staging and pathological staging. Clinical staging is based on test and scan results before any treatment begins. Pathological staging is more accurate and is based on examining tissue removed during surgery. If you undergo surgery, your stage might change once the pathologist examines the removed tissue under a microscope. This is because surgery allows doctors to see exactly how far the cancer has spread and how many lymph nodes are affected.^[2][12][17]

The grade of the cancer is another important piece of information. The grade describes how abnormal the cancer cells look under a microscope. Low-grade cancers (grade 1) have cells that look fairly similar to normal cells and tend to grow more slowly. High-grade cancers (grade 3) have cells that look very abnormal and tend to grow more aggressively. Stage III oesophageal squamous cell carcinoma can be any grade, and this information helps doctors predict how the cancer might behave and plan treatment accordingly.^[2][12][17]

Diagnostics for Clinical Trial Qualification

If you’re considering joining a clinical trial for stage III oesophageal squamous cell carcinoma, you’ll need to undergo specific diagnostic tests to determine whether you qualify. Clinical trials have strict entry criteria to ensure that the treatment being tested is appropriate for each participant and that the results of the study are meaningful and reliable.

Most clinical trials require confirmation of your cancer diagnosis through a biopsy. The biopsy report must clearly state that you have oesophageal squamous cell carcinoma and not another type of cancer. This is because different types of oesophageal cancer, such as adenocarcinoma, may respond differently to treatment, and mixing different cancer types in a single trial could make the results difficult to interpret.^[5][9]

Accurate staging is essential for clinical trial eligibility. Many trials are designed specifically for patients with stage III disease, so doctors need to be certain about your cancer stage before you can enroll. This typically involves a combination of imaging tests, including CT scans, MRI scans, and sometimes PET scans. These tests help determine the size and extent of the tumour, the number of affected lymph nodes, and whether the cancer has spread to distant sites.^[5][13]

Some clinical trials also require specific molecular or genetic tests on the tumour tissue. For example, trials testing immunotherapy drugs may require testing for a protein called PD-L1 (programmed death-ligand 1) on the cancer cells. Immunotherapy works by helping your immune system recognize and attack cancer cells, and the presence of PD-L1 can indicate whether a tumour is more likely to respond to this type of treatment. The test measures either the tumour proportion score (TPS), which looks at the percentage of cancer cells with PD-L1, or the combined positive score (CPS), which considers both cancer cells and certain immune cells.^[8][10][14]

For trials testing targeted therapies, additional molecular testing may be required. Some trials focus on cancers with specific genetic changes or protein markers. For instance, if a trial is testing a drug that targets the HER2 protein, your tumour will need to be tested to see if it produces high levels of HER2. This is more common in adenocarcinoma of the gastroesophageal junction, but some squamous cell cancers may also be tested for various molecular markers depending on the trial design.^[8][10]

Blood tests are also standard for clinical trial eligibility. These tests assess your overall health and organ function to ensure you’re strong enough to tolerate the trial treatment. Common blood tests include a complete blood count, which measures your red blood cells, white blood cells, and platelets, and tests of liver and kidney function. Trials may have specific requirements, such as minimum levels of certain blood cells or maximum levels of liver enzymes.^[5][13]

Your performance status, which measures your ability to carry out daily activities, is another important criterion for clinical trial eligibility. Doctors often use standardized scales to assess this, such as the Eastern Cooperative Oncology Group (ECOG) performance status scale, which ranges from 0 (fully active) to 5 (deceased). Most trials require patients to have a performance status of 0, 1, or 2, meaning you can perform most activities with little or no assistance.

Some trials may also require specific nutritional assessments. Since oesophageal cancer often affects your ability to eat and swallow, trials may have requirements about your weight or nutritional status. You might need to have a feeding tube placed before enrolling in a trial to ensure you can maintain adequate nutrition during treatment.^[8][10][21]

Finally, clinical trials typically require documentation of any previous cancer treatments you’ve received. This includes details about any surgery, chemotherapy, radiation therapy, or other treatments. Some trials are specifically for patients who have not yet received treatment, while others are designed for patients who have already tried certain therapies. Being honest and thorough about your treatment history is essential for determining whether a particular trial is right for you.